- Trials with a EudraCT protocol (6)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6 result(s) found for: Macular telangiectasia.
Displaying page 1 of 1.
EudraCT Number: 2017-004010-26 | Sponsor Protocol Number: THR-317-003 | Start Date*: 2018-08-03 | |||||||||||
Sponsor Name:ThromboGenics NV | |||||||||||||
Full Title: A Phase 2, open-label, multi-centre study to assess the efficacy and safety of intravitreal THR-317 for the treatment of macular telangiectasia Type 1 (MacTel 1) | |||||||||||||
Medical condition: Macular Telangiectasia Type 1 (MacTel 1) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006233-40 | Sponsor Protocol Number: CRFB002ADE04 | Start Date*: 2007-08-06 | |||||||||||
Sponsor Name:Department of Ophthalmology, Bonn University | |||||||||||||
Full Title: Ranibizumab in idiopathic macular telangiectasia, type2 A prospective interventional non-randomized study comparing the efficacy and safety of intravitreal ranibizumab (dosing regimen 0.5mg every ... | |||||||||||||
Medical condition: Typical findings in Type 2 idiopathic macular telangiectasia (type2-IMT)are parafoveal ectatic capillaries, The disease is characterized by a slow decrease in visual acuity, reading difficulties an... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001727-19 | Sponsor Protocol Number: 45/2006/U/Sper | Start Date*: 2006-10-03 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy | |||||||||||||
Medical condition: exudative maculopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003260-12 | Sponsor Protocol Number: NTMT-03-B | Start Date*: 2018-10-02 |
Sponsor Name:Neurotech Pharmaceuticals Inc. | ||
Full Title: A Phase 3 Multicenter Randomized, Sham-Controlled Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia type 2 | ||
Medical condition: Macular Telangiectasia type 2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003234-82 | Sponsor Protocol Number: NTMT-03-A | Start Date*: 2018-06-13 |
Sponsor Name:Neurotech Pharmaceuticals | ||
Full Title: A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia type 2 | ||
Medical condition: Macular Telangiectasia type 2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-003863-67 | Sponsor Protocol Number: FME_2018_9 | Start Date*: Information not available in EudraCT |
Sponsor Name:Fondation Ophtalmologique Adolphe de Rothschild | ||
Full Title: Multicenter randomized controlled trial on the interest of intravitreal injections of anti-VEGF as initial and adjuvant treatment in Coats disease | ||
Medical condition: Coats disease | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
